Panel Discussion: Tissue Sample Heterogeneity – Utilizing Cell Lines to Ensure Minimal Tumor Variation & Promote Clinical Efficacy
Time: 10:10 am
day: Day Two
Details:
• Explore how to harness cell lines to tackle the challenges surrounding cancer heterogeneity
• Produce a framework of how to overcome target resistance to produce an efficacious therapy
Speakers:
Courtney Andersen is a Senior Scientist in the In Vivo Bioscience group at AstraZeneca in Boston. In her current role, Courtney supports oncology drug discovery programs and is a core member of the preclinical combinations team. She has experience with various in vivo tumor models, including disseminated patient-derived xenograft models, and ex vivo culture systems.…Read more
Bahram Parvin received his Ph.D. from the University of Southern California in 1991. He then joined Lawrence Berkeley Lab, where he was a principal scientist with the Department of Cancer Biology from 2005-2014. In 2014, he joined the University of Nevada, Reno, as the Director of the Biomedical Engineering. The focus of his Laboratory has…Read more